Alembic Pharmaceuticals (BOM:533573) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533573 Alembic Pharmaceuticals Ltd BOM:533573
75 GF Score
Price ₹796.50
GF Value ₹1,054.49
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alembic Pharmaceuticals Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

BOM:533573
75GF Score
Alembic Pharmaceuticals Ltd BOM:533573
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alembic Pharmaceuticals (BOM:533573) Overvalued in 2026?

Based on GuruFocus' analysis, Alembic Pharmaceuticals stock appears to be undervalued. The current stock price of ₹796.50 is trading 24.5% below its estimated GF Value™ of ₹1,054.49. GuruFocus considers Alembic Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for BOM:533573:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹1,054.49 vs. price of ₹796.50 (24.5% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the BOM:533573 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alembic Pharmaceuticals Business Description

Other Exchanges APLLTD:India
Address Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities.
75GF Score

Get the complete analysis for BOM:533573

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹796.50
Price
₹1,054.49
GF Value